Umb Bank, N.A. Abb Vie Inc. Transaction History

Umb Bank, N.A.

$6.3 Billion
Q3 2024

A detailed history of Umb Bank, N.A. transactions in Abb Vie Inc. stock. As of the latest transaction made, Umb Bank, N.A. holds 142,903 shares of ABBV stock, worth $25.9 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

142,903

Previous 145,758 1.96%

Holding current value

$25.9 Million

Previous $25 Million 12.88%

% of portfolio

0.45%

Previous 0.42%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$163.84 - $199.33 $467,763 - $569,087	-2,855 Reduced 1.96%	142,903 $28.2 Million
Q2 2024 Jul 29, 2024	SELL	$154.79 - $180.76 $1.27 Million - $1.49 Million	-8,233 Reduced 5.35%	145,758 $25 Million
Q1 2024 Apr 26, 2024	SELL	$159.82 - $182.1 $4.62 Million - $5.26 Million	-28,892 Reduced 15.8%	153,991 $28 Million
Q4 2023 Jan 23, 2024	SELL	$137.6 - $154.97 $806,886 - $908,744	-5,864 Reduced 3.11%	182,883 $28.3 Million
Q3 2023 Oct 18, 2023	SELL	$133.59 - $154.65 $2.45 Million - $2.84 Million	-18,360 Reduced 8.86%	188,747 $28.1 Million
Q2 2023 Jul 25, 2023	SELL	$132.51 - $164.9 $10,865 - $13,521	-82 Reduced 0.04%	207,107 $27.9 Million
Q1 2023 Apr 11, 2023	BUY	$144.61 - $166.54 $209,106 - $240,816	1,446 Added 0.7%	207,189 $33 Million
Q4 2022 Jan 10, 2023	SELL	$138.31 - $165.87 $374,543 - $449,175	-2,708 Reduced 1.3%	205,743 $33.3 Million
Q3 2022 Oct 13, 2022	SELL	$134.21 - $153.93 $1.48 Million - $1.7 Million	-11,040 Reduced 5.03%	208,451 $28 Million
Q2 2022 Jul 20, 2022	BUY	$137.62 - $174.96 $558,186 - $709,637	4,056 Added 1.88%	219,491 $33.6 Million
Q1 2022 Apr 22, 2022	BUY	$131.98 - $163.75 $811,413 - $1.01 Million	6,148 Added 2.94%	215,435 $34.9 Million
Q4 2021 Feb 09, 2022	BUY	$107.43 - $135.93 $10.4 Million - $13.2 Million	97,021 Added 86.42%	209,287 $28.3 Million
Q3 2021 Oct 18, 2021	SELL	$106.4 - $120.78 $8.09 Million - $9.18 Million	-76,013 Reduced 40.37%	112,266 $12.1 Million
Q2 2021 Jul 26, 2021	BUY	$105.21 - $117.21 $436,726 - $486,538	4,151 Added 2.25%	188,279 $21.2 Million
Q1 2021 Apr 15, 2021	BUY	$102.3 - $112.62 $7.96 Million - $8.77 Million	77,852 Added 73.25%	184,128 $19.9 Million
Q4 2020 Feb 04, 2021	BUY	$80.49 - $108.67 $700,584 - $945,863	8,704 Added 8.92%	106,276 $11.4 Million
Q2 2020 Jul 16, 2020	BUY	$73.37 - $98.18 $5.34 Million - $7.14 Million	72,759 Added 293.23%	97,572 $9.58 Million
Q1 2020 May 26, 2020	SELL	$64.5 - $97.79 $141,964 - $215,235	-2,201 Reduced 8.15%	24,813 $1.89 Million
Q4 2019 Jan 31, 2020	SELL	$72.13 - $90.25 $25,101 - $31,407	-348 Reduced 1.27%	27,014 $2.39 Million
Q3 2019 Oct 30, 2019	SELL	$62.98 - $75.72 $1.78 Million - $2.14 Million	-28,209 Reduced 50.76%	27,362 $2.07 Million
Q2 2019 Jul 30, 2019	SELL	$65.7 - $83.98 $356,225 - $455,339	-5,422 Reduced 8.89%	55,571 $4.04 Million
Q1 2019 Apr 30, 2019	SELL	$77.14 - $90.79 $2.74 Million - $3.23 Million	-35,528 Reduced 36.81%	60,993 $4.92 Million
Q4 2018 Jan 24, 2019	SELL	$77.85 - $96.01 $234,406 - $289,086	-3,011 Reduced 3.03%	96,521 $8.9 Million
Q3 2018 Oct 22, 2018	SELL	$88.91 - $98.84 $12.7 Million - $14.1 Million	-142,547 Reduced 58.88%	99,532 $9.41 Million
Q2 2018 Jul 31, 2018	BUY	$89.78 - $106.23 $1.72 Million - $2.03 Million	19,136 Added 8.58%	242,079 $22.4 Million
Q1 2018 Apr 25, 2018	BUY	$92.01 - $123.21 $262,136 - $351,025	2,849 Added 1.29%	222,943 $21.1 Million
Q4 2017 Jan 22, 2018	BUY	$89.56 - $98.21 $1.73 Million - $1.89 Million	19,293 Added 9.61%	220,094 $21.3 Million
Q3 2017 Oct 11, 2017	BUY	$69.85 - $89.22 $14 Million - $17.9 Million	200,801	200,801 $17.8 Million

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $321B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Umb Bank, N.A. with notifications on news.

Account